Published in Medical Letter on the CDC and FDA, January 23rd, 2005
The new 500 mg formulation will significantly reduce Invirase's pill count by more than half, from five to two pills twice a day. With less tablets per day, Invirase now becomes an excellent choice for HIV-patients who require treatment with an HIV-protease inhibitor.
"With the new Invirase 500 mg tablet now available, pill burden is considerably reduced and we anticipate that this improved convenience together with boosted Invirase's record of convincing data will result in an expansion of its...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA